Vasopressine lors d'infarctus myocardique aigu: implications cliniques [Vasopressin in acute myocardial infarct: clinical implications]

Details

Serval ID
serval:BIB_B82A08F39F29
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Vasopressine lors d'infarctus myocardique aigu: implications cliniques [Vasopressin in acute myocardial infarct: clinical implications]
Journal
Schweizerische medizinische Wochenschrift
Author(s)
Schaller M.D., Nicod P., Nussberger J., Feihl F., Waeber B., Brunner H.R., Perret C.
ISSN
0036-7672
Publication state
Published
Issued date
1986
Peer-reviewed
Oui
Volume
116
Number
49
Pages
1727-9
Language
french
Notes
Publication types: English Abstract ; Journal Article - Publication Status: ppublish
Abstract
Since current data on vasopressin (AVP) secretion during the early phase of myocardial infarction is not extensive, plasma AVP was measured in 26 patients with acute myocardial infarction. Twelve had an increased AVP concentration (23.2 +/- 7.0 pg/ml; mean +/- SEM) whereas 14 had an AVP level less than 3 pg/ml (1.96 +/- 0.14 pg/ml). The patients with AVP greater than 3 pg/ml had higher heart rate and plasma osmolality than those with AVP less than 3 pg/ml. Blood pressure values were the same in both groups of patients. There was no difference in peak CPK and iso CPK activities between the two groups. Seven patients with AVP greater than 3 pg/ml died within the next few days, while only 1 patient with AVP less than pg/ml died. It thus appears that increased AVP concentration during acute myocardial infarction is associated with a poor prognosis. Whether it is a cause or a consequence of an unfavourable course of myocardial infarction remains to be determined.
Keywords
Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Myocardial Infarction, Prognosis, Vasopressins
Pubmed
Web of science
Create date
05/03/2008 16:40
Last modification date
20/08/2019 15:26
Usage data